Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 4
2007 4
2008 2
2009 4
2010 5
2011 4
2012 6
2013 6
2014 11
2015 17
2016 9
2017 6
2018 9
2019 9
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Results by year
Filters applied: . Clear all
Page 1
The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study.
Kuriya B, Vigod S, Luo J, Widdifield J, Haroon N. Kuriya B, et al. Among authors: Haroon N. PLoS One. 2020 Feb 21;15(2):e0229273. doi: 10.1371/journal.pone.0229273. eCollection 2020. PLoS One. 2020. PMID: 32084192 Free PMC article.
Further evaluation of at-risk AS subjects is needed, including the longitudinal effects of disease and arthritis therapies on self-harm behaviour. This will inform whether specific risk-reduction strategies for DSH in inflammatory arthritis are needed....
Further evaluation of at-risk AS subjects is needed, including the longitudinal effects of disease and arthritis therapies on self-ha …
Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
Sari I, Lee S, Tomlinson G, Johnson SR, Inman RD, Haroon N. Sari I, et al. Among authors: Haroon N. Arthritis Care Res (Hoboken). 2019 Nov 1. doi: 10.1002/acr.24104. Online ahead of print. Arthritis Care Res (Hoboken). 2019. PMID: 31675169
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L. Ward MM, et al. Among authors: Haroon N. Arthritis Rheumatol. 2019 Oct;71(10):1599-1613. doi: 10.1002/art.41042. Epub 2019 Aug 22. Arthritis Rheumatol. 2019. PMID: 31436036
Sulfasalazine is recommended only for persistent peripheral arthritis when TNFi are contraindicated. For patients with unclear disease activity, spine or pelvis magnetic resonance imaging could aid assessment. ...
Sulfasalazine is recommended only for persistent peripheral arthritis when TNFi are contraindicated. For patients with unclear diseas …
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L. Ward MM, et al. Among authors: Haroon N. Arthritis Care Res (Hoboken). 2019 Oct;71(10):1285-1299. doi: 10.1002/acr.24025. Epub 2019 Aug 21. Arthritis Care Res (Hoboken). 2019. PMID: 31436026
Sulfasalazine is recommended only for persistent peripheral arthritis when TNFi are contraindicated. For patients with unclear disease activity, spine or pelvis magnetic resonance imaging could aid assessment. ...
Sulfasalazine is recommended only for persistent peripheral arthritis when TNFi are contraindicated. For patients with unclear diseas …
Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders.
Fiorillo MT, Haroon N, Ciccia F, Breban M. Fiorillo MT, et al. Among authors: Haroon N. Front Immunol. 2019 Jun 4;10:1232. doi: 10.3389/fimmu.2019.01232. eCollection 2019. Front Immunol. 2019. PMID: 31214188 Free PMC article. No abstract available.
Disease modification in axial spondyloarthritis.
Sari I, Haroon N. Sari I, et al. Among authors: Haroon N. Best Pract Res Clin Rheumatol. 2018 Jun;32(3):427-439. doi: 10.1016/j.berh.2019.02.007. Epub 2019 Mar 2. Best Pract Res Clin Rheumatol. 2018. PMID: 31171313 Review.
Recent advances in spondyloarthritis.
Poddubnyy D, Haroon N. Poddubnyy D, et al. Among authors: Haroon N. Best Pract Res Clin Rheumatol. 2018 Jun;32(3):329-330. doi: 10.1016/j.berh.2019.03.014. Epub 2019 Apr 13. Best Pract Res Clin Rheumatol. 2018. PMID: 31171305 No abstract available.
Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and Rheumatologists.
Passalent L, Hawke C, Lawson DO, Omar A, Alnaqbi KA, Wallis D, Steinhart H, Silverberg M, Wolman S, Derzko-Dzulynsky L, Haroon N, Inman RD. Passalent L, et al. Among authors: Haroon N. J Rheumatol. 2020 Apr;47(4):524-530. doi: 10.3899/jrheum.180787. Epub 2019 May 1. J Rheumatol. 2020. PMID: 31043543
CONCLUSION: ERP with specialty training in inflammatory arthritis demonstrate clinical impressions comparable with those of rheumatologists in the assessment of axSpA. ...
CONCLUSION: ERP with specialty training in inflammatory arthritis demonstrate clinical impressions comparable with those of rheumatol …
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.
Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landewé R, Rudwaleit M, Hall S, Bauer L, Hoepken B, de Peyrecave N, Kilgallen B, van der Heijde D. Deodhar A, et al. Among authors: Haroon N. Arthritis Rheumatol. 2019 Jul;71(7):1101-1111. doi: 10.1002/art.40866. Epub 2019 May 28. Arthritis Rheumatol. 2019. PMID: 30848558 Free PMC article. Clinical Trial.
89 results
Jump to page
Feedback